OPRX — OptimizeRx Corp
—
Nasdaq ·
Industrials ·
Professional Services ·
CIK 1448431 ·
Last close
$6.94
Market Cap
$130.72M
52W High
$15.59
52W Low
$4.54
ADV30
218,027
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 21,615,000 | 16,246,000 | 2,670,000 | 1,195,000 | 162,093,000 | 22,325,000 | 28,215,000 |
| Jun 2026 | 20,504,000 | 15,688,000 | -88,000 | -703,000 | 164,317,000 | 24,096,000 | 33,235,000 |
| Mar 2026 | 19,844,000 | 14,932,000 | 396,000 | -495,000 | 167,264,000 | 20,169,000 | 37,653,000 |
| Dec 2025 | 32,239,000 | 24,100,000 | 8,937,000 | 5,020,000 | 176,918,000 | 23,365,000 | 48,624,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$18,434,000
Investing CF
$140,000
Financing CF
$-11,074,000
CapEx
$-110,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.23
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-80,434,000
Inventory
—
Receivables
$27,124,000
ST Investments
—
EBIT TTM
$11,457,000
Pretax Income TTM
$6,780,000
Interest Exp TTM
$4,677,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$98,654,000
EBITDA
$15,551,000
Free Cash Flow
$15,760,875
Enterprise Value
$163,965,760
Total Cash
$24,096,000
Total Debt
$19,480,000
Shares Out
18,835,951
Trailing EPS
$0.20
Book Value
$6.84
ROE
3.7%
ROA
4.2%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 109,429,000 | 12,061,000 | 5,132,000 | 176,918,000 | 48,624,000 | 128,294,000 | 18,715,000 |
| Dec 2024 | 92,127,000 | -6,217,000 | -20,110,000 | 171,168,000 | 54,170,000 | 116,998,000 | 4,889,000 |
| Dec 2023 | 71,522,000 | -17,522,000 | -17,566,000 | 183,374,000 | 56,821,000 | 126,553,000 | -7,240,000 |
| Dec 2022 | 62,450,156 | -12,290,738 | -11,438,440 | 134,651,185 | 8,540,408 | 126,110,777 | 10,654,078 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$98,654,000
NetIncome TTM
$4,601,000
OpCashFlow TTM
—
Assets (Latest)
$164,317,000
Forward EPS
$1.03
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $7.31 · call volume: 28 · put volume: 8
Expected Move to 2026-12-18:
±$1.50
(20.52%) —
implied range
$5.81 –
$8.81
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TTEC | TTEC Holdings, Inc. | $160.00M | $3.24 | — |
| PSFE | Paysafe Ltd | $162.39M | $3.11 | — |
| MACI | Melar Acquisition Corp. I/Cayman | $164.97M | $7.63 | — |
| RYDE | Ryde Group Ltd | $168.06M | $1.12 | — |
| IMXI | International Money Express, Inc. | $169.23M | $5.60 | — |
News headlines (Yahoo Finance, 1h cache)
OptimizeRx to Participate in the 15th Annual ROTH Technology Conference
2026-11-16 12:30 · Yahoo
OptimizeRx Corp (OPRX) (Q3 2026) Earnings Call Highlights: Margin Expansion and Programmatic ...
2026-11-12 15:04 · Yahoo
OptimizeRx Corporation Q3 2026 Earnings Call Summary
2026-11-12 13:30 · Yahoo
OptimizeRx (OPRX) Q3 2026 Earnings Call Transcript
2026-11-12 06:32 · Yahoo
What OptimizeRx (OPRX) Said on Its Q3 Earnings Call
2026-11-12 00:13 · Yahoo
OptimizeRx Corp. (OPRX) Q3 Earnings and Revenues Beat Estimates
2026-11-11 21:10 · Yahoo
OptimizeRx Reports Third Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
2026-11-11 21:01 · Yahoo
OptimizeRx Sets Third Quarter 2026 Conference Call for November 11, 2026 at 4:30 p.m. ET
2026-10-28 11:30 · Yahoo
OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel
2026-10-27 11:30 · Yahoo
OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad Network
2026-09-22 17:18 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.